Basil Drugs & Pharmaceuticals Pvt. Ltd.

Basil Drugs & Pharmaceuticals Pvt. Ltd. is a sourcing agent and strategic marketing partner for various pharmaceutical marketing and manufacturing companies. With a strong focus on the pharmaceutical industry, the company offers expertise in API, intermediates, and finished dosage forms, coupled with extensive relationships in the Indian and global pharmaceutical marketplace. Specializing in the manufacturing of oncology, critical care, and generic pharma products for domestic and export markets, Basil Drugs & Pharmaceuticals provides a wide array of API offerings. The company's offerings include an extensive range of APIs such as benfotiamine, bicalutamide, celecoxib, citalopram hydrobromide, and many more. Additionally, they cater to the needs of their clients for API, intermediates, finished formulations, and contract manufacturing. Basil Drugs & Pharmaceuticals caters to the healthcare, manufacturing, pharmaceutical, and marketing industries. The company, headquartered in India, was founded in 2018 and has positioned itself as a valuable player in the pharmaceutical ecosystem. For investors interested in exploring opportunities in the pharmaceutical industry, Basil Drugs & Pharmaceuticals holds the potential for investment or strategic partnerships. With its vast array of API offerings and expertise in pharmaceutical manufacturing, the company presents an attractive prospect for investors seeking exposure to the pharmaceutical and healthcare sectors in India.